东睦新材料集团延长重大资产重组决议有效期，交易进程仍在推进
要点摘要
- 公司计划以发行股份及支付现金方式收购上海富驰高科技34.75%股权，并募集配套资金。
- 本次重大资产重组已获上海证券交易所审核通过，但尚未取得中国证监会注册批复。
- 原定股东会决议及授权有效期即将届满，公司拟将有效期延长12个月至2027年6月23日。
- 若在有效期内获得证监会注册批复，有效期将自动延长至交易实施完毕。
- 此次延长期限的议案仍需提交2026年第一次临时股东会审议。
详细解读
东睦新材料集团股份有限公司（证券代码：600114，股票简称：东睦股份）于2026年6月12日召开第九届董事会第十次会议，通过了延长本次发行股份及支付现金购买资产并募集配套资金股东会决议有效期及相关授权期限的议案。
该重大资产重组自2025年6月23日公司临时股东会审议通过以来，原定决议及授权有效期为12个月。然而，因交易尚未获得中国证监会注册，公司尚未完成交易实施。为保证交易的持续和顺利推进，公司拟将上述有效期再延长12个月，即至2027年6月23日。
此次交易涉及以发行股份及支付现金方式，向深圳市远致星火私募股权投资基金合伙企业（有限合伙）、钟伟、上海创精投资咨询合伙企业（有限合伙）、宁波华莞企业管理合伙企业（有限合伙）、宁波富精企业管理合伙企业（有限合伙）等5名交易对方，购买其合计持有的上海富驰高科技股份有限公司34.75%股权，同时募集配套资金。
值得注意的是，本次交易已经上海证券交易所审核通过，显示出项目符合交易所的相关要求，但由于尚未取得中国证监会的最终注册批复，交易尚未进入实施阶段。若在延长期内获得证监会批复，有效期将自动延长至交易实施完成日。
除了延长决议有效期外，交易方案及授权内容均未发生其他变化。此次延长期限的议案将提交2026年第一次临时股东会审议。
对股东及市场的潜在影响
- 进展延迟：此次延长有效期反映出重大资产重组进展慢于预期，主因在于证监会注册流程未完成。这可能引发市场对交易最终能否顺利落地的关注，并对股价带来波动。
- 交易持续推进：交易已获上交所审核通过，显示公司重大资产重组在监管层面具备一定合规性和可行性，若顺利注册，有望提升公司核心竞争力和资产规模。
- 不确定性风险：若后续证监会注册审核不顺利，交易存在进一步延期甚至搁置的可能性，对公司估值和投资者信心产生影响。
- 未来催化剂：一旦获得证监会注册批复，交易正式实施有望成为公司业绩增长和市值提升的新催化剂，建议投资者密切关注后续进展和公告。
结语
综合来看，东睦新材料集团此次延长重大资产重组相关决议有效期，是公司确保交易顺利推进的必要举措。尽管交易进展慢于预期，但获上交所通过后仍具备较强实施可能性。投资者需关注证监会注册进展及后续实施细节，相关进展对公司估值及股价或有实质影响。
免责声明：本文内容仅供投资者参考，不构成任何投资建议。投资有风险，入市需谨慎。请投资者密切关注公司公告和市场动态，做出独立判断。
English Version
NBTM New Materials Announces Extension of Major Asset Restructuring Resolution Validity, Transaction Still in Progress
Key Highlights
- The company plans to acquire a 34.75% stake in Shanghai Fuchi High-tech via share issuance and cash payment, and to raise supporting funds.
- The major asset restructuring has been approved by the Shanghai Stock Exchange but is still pending registration by the China Securities Regulatory Commission (CSRC).
- The original shareholder meeting resolution and authorization validity period are about to expire; the company proposes to extend it by 12 months to June 23, 2027.
- If the CSRC registration approval is obtained within the validity period, the authorization will automatically extend until the transaction is completed.
- This extension proposal is subject to approval at the company’s first extraordinary general meeting of shareholders in 2026.
Detailed Interpretation
NBTM New Materials Group Co., Ltd. (Stock Code: 600114, Stock Abbreviation: NBTM) held its 10th meeting of the 9th Board of Directors on June 12, 2026, and approved the proposal to extend the validity period of the resolution for the current share issuance, cash purchase of assets, and supporting fund-raising, as well as the related authorization period.
Since the major asset restructuring was approved at the extraordinary shareholders’ meeting on June 23, 2025, the original resolution and authorization validity period was set at 12 months. However, as the transaction has not yet obtained CSRC registration, it has not been completed. To ensure continued and smooth progress, the company intends to extend the validity period by another 12 months, until June 23, 2027.
This transaction involves the issuance of shares and cash payment to five counterparties—Shenzhen Yuanzhi Xinghuo Private Equity Fund Partnership (Limited Partnership), Zhong Wei, Shanghai Chuangjing Investment Consulting Partnership (Limited Partnership), Ningbo Huaguan Enterprise Management Partnership (Limited Partnership), and Ningbo Fujing Enterprise Management Partnership (Limited Partnership)—to acquire a combined 34.75% stake in Shanghai Fuchi High-tech Co., Ltd., while raising supporting funds.
Notably, the transaction has already passed review by the Shanghai Stock Exchange, indicating that it meets the relevant requirements of the exchange. However, as final CSRC registration is still pending, the transaction has not yet entered the implementation stage. If CSRC approval is obtained within the extended period, the validity will automatically extend until the transaction is completed.
Aside from the extension of the validity period, other aspects of the transaction plan and authorization remain unchanged. The extension proposal will be submitted to the company’s first extraordinary general meeting of shareholders in 2026 for approval.
Potential Impact on Shareholders and the Market
- Progress Delay: The extension reflects slower-than-expected progress in the major asset restructuring, mainly due to pending CSRC registration. This may trigger market concerns about whether the transaction will be completed, potentially causing share price volatility.
- Transaction Ongoing: The transaction’s approval by the Shanghai Stock Exchange demonstrates regulatory compliance and feasibility. Successful CSRC registration could enhance the company’s core competitiveness and asset scale.
- Uncertainty Risk: If CSRC registration faces further delays or obstacles, there is a risk of additional postponement or even cancellation, which could impact valuation and investor confidence.
- Future Catalyst: Upon CSRC registration, completion of this asset restructuring could become a new catalyst for company performance and market value. Investors are advised to closely monitor future developments and disclosures.
Conclusion
In summary, NBTM’s extension of the validity period for this major asset restructuring is a necessary step to ensure smooth progress. Although the process is slower than expected, the transaction’s approval by the exchange gives it a strong likelihood of completion. Investors should keep a close watch on CSRC registration progress and subsequent implementation, as these developments could have a material impact on company valuation and share price.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investing involves risks. Please pay close attention to company announcements and market developments and make independent decisions.
